Impairment of ganglioside metabolism in cultured fibroblasts from Salla patients

Clinica Chimica Acta

Volumn 247, Issue 1-2, 1996, Pages 143-157

  Pitto, Marina ^a   Chigorno, Vanna ^a   Renlund, Martin ^b   Tettamanti, Guido ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

cultured fibroblast; ganglioside metabolism; Salla disease; sialic acid

Indexed keywords

GANGLIOSIDE GM1; SIALIC ACID;

ARTICLE; CASE REPORT; CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; ISOTOPE LABELING; METABOLIC DISORDER; METABOLISM; NORMAL HUMAN; PATHOGENESIS; PRIORITY JOURNAL; SKIN FIBROBLAST;

EID: 0029940662     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-8981(95)06243-2     Document Type: Article

References (34)

1. Gahl WA, Renlund M, Thoene JG. Lysosomal transport disorders: cystinosis and sialic acid storage disorders. In: Scriver CR, Beaudet, AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease, 6th edition. New York: McGraw-Hill, 1989, Ch. 107; 2619-2647.
2. Weiss P, Tietze F, Gahl WA, Seppala R, Ashwell G. Identification of the Metabolic Defect in Sialuria. J Biol Chem 1989;264:17675-17686.
3. Renlund M, Kovanen PT, Raivio KO, Aula P, Gahmberg CG, Ehnholm C. Studies on the defect underlying the lysosomal storage of sialic acid in Salla disease. J Clin Invest 1986;77:568-574.
4. Mancini GMS, Verheijen FW, Galjaard H. Free N-acetylneuraminic acid (NANA) storage disorders: evidence for defective NANA transport across the lysosomal membrane. Hum Genet 1986;73:214-217.
5. Blom HJ, Andersson HC, Seppala R, Tietze F, Gahl WA. Defective glucuronic acid transport from lysosomes of infantile free sialic acid storage disease fibroblasts. Biochem J 1990;268:621-625.
6. Mancini GMS, de Jonge HR, Galjaard H, Verheijen FW. Characterization of proton-driven carrier for sialic acid in the lysosomal membrane. Evidence for a group-specific transport system for acidic monosaccharides. J Biol Chem 1989;264:15247-15254.
7. Renlund M, Chester MA, Lundblad A, Parkkinen J, Krusius T. Free N-acetylneuraminic acid in tissues in Salla disease and the enzymes involved in its metabolism. Eur J Biochem 1983;130:39-45.
8. Hancock LW, Horwitz AL, Dawson G. N-Acetylneuraminic acid and sialoglycoconjugate metabolism in fibroblasts from a patient with generalized N-acetylneuraminic acid storage disease. Biochim Biophys Acta 1983;760:42-52.
9. Thomas GH, Scocca J, Libert J, Vamos E, Miller CS, Reynolds LW. Alteration in cultured fibroblasts of sibs with an infantile form of a free (unbound) sialic acid storage disorders. Pediatr Res 1983;17:307-312.
10. Stevenson RE, Lubinsky M, Taylor HA, Wenger DA, Schroer RJ, Olmstead PM. Sialic acid storage disease with sialuria: clinical and biochemical features in the severe infantile type. Pediatrics 1983;72:441-449.
11. Van Echten G, Sandhoff K. Ganglioside metabolism. Enzymology, topology, regulation. J Biol Chem 1993;268:5341-5344.
12. Riboni L, Tettamanti G. Ganglioside turnover and formation of metabolic regulators. Trends Glycobiol Glycotechnol 1993;5:1-11.
13. Ghidoni R, Trinchera M, Sonnino S, Chigorno V, Tettamanti G. The sialic acid of exogenous GM1 ganglioside is recycled for biosynthesis of sialoglycoconjugates in rat liver. Biochem J 1987;247:157-164.
14. Merrill AH Jr. Cell regulation by sphingosine and more complex sphingolipids. J Bioenerg Biomembr 199;23:83-104.
15. Hannun YA. The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 1994;269:3125-3128.
16. Tettamanti G, Bonali F, Marchesini S, Zambotti V. A new procedure for the extraction and purification of brain gangliosides. Biochim Biophys Acta 1973;296:160-170.
17. Ghidoni R, Sonnino S, Masserini M, Orlando P, Tettamanti G. Specific tritium labeling of gangliosides at the 3-position of sphingosines. J Lipid Res 1981;22;1286-1295.
18. Sonnino S, Ghidoni R, Gazzotti G, Kirschner G, Galli G, Tettamanti G. High performance liquid chromatography preparation of the molecular species of GM1 and GD1a gangliosides with homogeneous long chain base composition. J Lipid Res 1984;25:620-629.
19. 14C]-labeled at the sialic acid acetyl group. Glycoconjugate J 1985;2:279-291.
20. Leroy JG, Ho WM, MacBrinn MC, Zielke K, Jacob J, O'Brien JS. I-Cell disease: biochemical studies. Pediatr Res 1972;6:752-757.
21. Midorikawa M, Inui K, Okada S, Yabuuchi H, Ogura K, Handa S. Uptake and metabolism of radiolabelled GM1-ganglioside in skin fibroblasts from controls and patients with GM1-gangliosidosis. J Inherit Metab Dis 1991;14:721-729.
22. Giglioni A, Pitto M, Chigorno V, Zorzino L, Ghidoni R. Subcellular metabolism of exogenous GM1 ganglioside in normal human fibroblasts. Biochem Int 1990;247:157-164.
23. Kint JA. Fabry's disease: alpha-galactosidase deficiency. Science (Washington, DC) 1970;176: 1268-1269.
24. Kopitz J, von Reitzenstein C, Mühl C, Cantz M. Role of plasma membrane ganglioside sialidase of human neuroblastoma cells in growth control and differentiation. Biochem Biophys Res Commun 1994;199:1188-1193.
25. Sonnino S, Chigorno V, Acquotti D, Pitto M, Kirschner G, Tettamanti G. A photoreactive derivative of radiolabeled GM1 ganglioside: preparation and use to establish the involvement of specific proteins in GM1 uptake by human fibroblasts in culture. Biochemistry 1989;28:77-84.
26. Svennerholm L. Quantitative estimation of sialic acids. II. A colorimetric resorcinolhydrochloric acid method. Biochim Biophys Acta 1957;24:604-611.
27. Peterson GL. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 1977;83:346-356.
28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-275.
29. Bradford MM. Protein assay by dye binding. Anal Biochem 1976;72:248-252.
30. Mendia K, Baumkötter J, Rosenau C, Ulrich-Bott B, Cantz M. Defective lysosomal release of glycoprotein-derived sialic acid in fibroblasts from patients with sialic acid storage disease. Biochem J 1988;250:261-267.
31. Schneider-Jacob HR, Cantz M. Lysosomal and plasma membrane ganglioside GM3 sialidases of cultured human fibroblasts. Differentiation by detergents and inhibitors. Biol Chem Hoppe-Seyler 1991;372:443-450.
32. Ulrich-Bott B, Lieser M, Schwarzmann G, Cantz M. Ganglioside accumulation and degradation in fibroblasts from patients with sialidosis, mucolipidosis II, IV and sialic acid storage disease. In: Schauer R, Yamakawa T, eds. Sialic acid 1988. Kiel: Barbel-MendeVerlag, 1988;174-175.
33. Baumkötter J, Cantz M, Mendia K, Baumann W, Friebolin H, Gehler J. Spranger, N-Acetylneuraminic acid storage disease. J Hum Genet 1985;71:155-159.
34. Svennerholm L. Structure and function of gangliosides. In: Svennerholm L, Mandel P, Dreyfus H, Urban PF, eds. Adv Exp Med Biol 1980;125:11-21.